CINECA IRIS Institutional Research Information System

MUCCIOLI, Giampiero Gerardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.203
NA - Nord America 3.805
AS - Asia 1.188
AF - Africa 25
OC - Oceania 21
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 9
Totale 9.272
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.702
IT - Italia 1.251
CN - Cina 718
IE - Irlanda 438
UA - Ucraina 436
FR - Francia 434
SE - Svezia 380
DE - Germania 350
FI - Finlandia 287
KR - Corea 269
AT - Austria 175
GB - Regno Unito 148
PL - Polonia 109
CA - Canada 71
VN - Vietnam 59
DK - Danimarca 52
IN - India 36
JP - Giappone 36
BE - Belgio 31
MX - Messico 30
NL - Olanda 29
RU - Federazione Russa 28
UZ - Uzbekistan 17
AU - Australia 16
SN - Senegal 15
SG - Singapore 13
ES - Italia 12
BR - Brasile 10
EU - Europa 9
IR - Iran 9
CZ - Repubblica Ceca 7
TW - Taiwan 7
TR - Turchia 6
AR - Argentina 5
NZ - Nuova Zelanda 5
PH - Filippine 5
RO - Romania 5
CH - Svizzera 4
EG - Egitto 4
PT - Portogallo 4
CO - Colombia 3
HR - Croazia 3
HU - Ungheria 3
ID - Indonesia 3
NG - Nigeria 3
NO - Norvegia 3
AL - Albania 2
BG - Bulgaria 2
GR - Grecia 2
MK - Macedonia 2
MU - Mauritius 2
NP - Nepal 2
PA - Panama 2
PK - Pakistan 2
SA - Arabia Saudita 2
SM - San Marino 2
AM - Armenia 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
IL - Israele 1
LK - Sri Lanka 1
LT - Lituania 1
ME - Montenegro 1
MY - Malesia 1
PE - Perù 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.272
Salva come PNG Salva come JPEG
Città #
Chandler 613
Beijing 560
Dublin 438
Villeurbanne 317
Jacksonville 260
Houston 253
Ann Arbor 204
Vienna 174
Dearborn 168
Medford 150
Princeton 148
Nyköping 139
Milan 137
Warsaw 103
Ashburn 102
Wilmington 96
Fairfield 90
Torino 75
Rome 70
Boston 64
New York 59
Redwood City 48
Boardman 47
Woodbridge 45
Fremont 44
Turin 40
Cambridge 37
Seattle 35
Verona 32
Dong Ket 31
Pisa 29
Toronto 29
Helsinki 23
Norwalk 23
Brussels 22
Falls Church 19
Lachine 19
Pescara 19
Nanjing 17
Naples 17
Seongnam 16
Shanghai 15
Bari 13
Florence 13
Guangzhou 13
Hefei 13
Kunming 13
London 13
Detroit 12
Munich 11
Zhengzhou 11
Bologna 10
Brescia 10
Tappahannock 10
Genoa 9
Palermo 9
Pune 9
Washington 9
Gattico 8
Jinan 8
Modugno 8
Mountain View 8
Philadelphia 8
San Diego 8
San Mateo 8
Trieste 8
Catania 7
Düsseldorf 7
Hebei 7
Berlin 6
Follonica 6
Nuillé-sur-vicoin 6
Puebla City 6
Tokyo 6
Busto Arsizio 5
Edinburgh 5
Greve in Chianti 5
Hangzhou 5
Livorno 5
Mestrino 5
Prague 5
Reggio Calabria 5
Silver Spring 5
Taipei 5
Wuhan 5
Amsterdam 4
Arzignano 4
Chengdu 4
Como 4
Fuzhou 4
Honolulu 4
Indianapolis 4
Limatola 4
Lisbon 4
Messina 4
Montefalcone di Val Fortore 4
Munro 4
Nanchang 4
Osaka 4
Paderno Dugnano 4
Totale 5.235
Salva come PNG Salva come JPEG
Nome #
Farmacologia generale e clinica 1.176
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines 309
Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin 275
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours 239
Ghrelin and Des-Acyl Ghrelin Promote Differentiation and Fusion of C2c12 Skeletal Muscle Cells 193
ACYLATED AND UNACYLATED GHRELIN PROMOTE PROLIFERATION AND INHIBIT SERUM STARVATION- AND CYTOKINE-INDUCED APOPTOSIS OF PANCREATIC BETA-CELLS AND HUMAN ISLETS. INVOLVEMENT OF cAMP/PKA, ERK1/2 AND PI3K/AKT SIGNALING 151
Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. 148
Farmacologia generale e clinica 98
Alkaloid Profiles and Activity in Different Mitragyna speciosa Strains 94
Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans 93
Growth hormone-releasing peptides. 92
Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling 92
Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. 91
Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats 91
A sensitive experimental model for the assessment of hepatotoxicity by halogenocompounds: prolactin binding to the specific receptors 89
Correlative studies on the presence of oestrogen and prolactin receptors and histology in human breast carcinomas 85
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans 85
Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function 84
The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans 83
Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase γ and phosphodiesterase 3B. 83
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV 81
Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland 80
Biologic activities of growth hormone secretagogues in humans. 78
Growth hormone secretagogue binding sites in peripheral human tissues. 78
Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences 78
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma 77
Cardiac effects of hexarelin in hypopituitary adults. 77
Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes 76
d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans 74
Ghrelin: endocrine, metabolic and cardiovascular actions 72
Ghrelin: much more than a natural growth hormone secretagogue. 71
Biochemical study of prolactin binding sites in Xenopus laevis brain and choroid plexus 70
Hyperprolactinaemia and prolactine binding in benign intracranial tumours. 68
TYR-ALA-HEXARELIN, A SYNTHETIC OCTAPEPTIDE, HAS THE SAME ENDOCRINE ACTIVITIES OF HEXARELIN AND GHRP-2 IN HUMANS 67
Ghrelin and prostate cancer 65
EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. 65
Ovine prolactin administration modifies [3H]spiperone binding to striatal membranes of rabbits. 65
Specific prolactin binding to rabbit brain membranes. 65
Insulin-like growth factor binding protein-3 mediates serum starvation- and doxorubicin-induced apoptosis in H9c2 cardiac cells. 65
Unacylated as well as acylated ghrelin promotes cell survival and inhibit apoptosis in HIT-T15 pancreatic beta-cells 64
Brain-gut communication: cortistatin, somatostatin and ghrelin 64
Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin 62
Growth hormone secretagogues, synthesis and biological evaluation 62
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. 62
Prolactin receptor and interrenal hormone levels in adult Xenopus laevis (Daudin) exposed to hyperosmotic stress and treated with metyrapone. 62
Endocrine activities of alexamorelin (Ala-His-d-2-methyl-Trp-Ala-Trp-d-Phe-Lys-NH2), a synthetic GH secretagogue, in humans 61
Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland. 60
Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors 60
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. 60
Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 smal cell carcinoma cell line 60
Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. 60
Boosting the efficacy of doxorubicin against ovarian cancer by ultrasound stimulation 60
Prolactin receptors in human meningiomas: characterization and biological role. 59
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21. 59
Cardiac effects of hexarelin in hypopituitary adults 59
Known and unknown growth hormone secretagogue receptors and their ligands 58
Effects of long-term administration of high doses of medroxyprogesterone acetate on hormone receptors and target organs in the female rat. 57
Ormoni dell’ipofisi posteriore 57
CARDIOVASCULAR ACTIVITIES OF NATURAL AND SYNTHETIC GH SECRETAGOGUES 57
The dopaminergic system and breast disease: novel approaches to pathophysiology and treatment. 56
Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors 56
Further study on the changes in the concentration of prolactin-binding sites in different organs of Xenopus laevis male and female, kept under dry conditions and then returned to water (their natural habitat) 55
Prolactin and interrenal hormone balance in adult specimens of Xenopus laevis exposed to hyperosmotic stress for up to one week. 55
Beyond the metabolic role of ghrelin: a new player in the regulation of reproductive function 55
Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. 55
Normal development of lymphokine activated killing (LAK) in peripheral blood lymphocytes from hyperprolactinemic patients. 54
Somatostatin, cortistatin and their receptors in tumours 54
Endocrine responses to GH secretagogues in relation to sex and age in humans 54
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. 54
Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans 54
Effetto di GH e/o IGF-I esogeni sulla crescita di colture primarie di fibroblasti di pazienti ustionati. 53
Endocrine and non-endocrine actions of ghrelin and GHS: state of the art in clinic research. 53
Prolactin binding sites in Xenopus laevis tissues: comparison between normal and dehydrated animals 53
Prolactin receptors in human choroid plexus. 52
Farmacologia degli ormoni dell'ipofisi posteriore 52
Modification of prolactin receptor levels induced by pharmacological treatments in R3230AC rat mammary tumors. 51
Impervious peptides as growth hormone secretagogues. 51
Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery. 51
Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. 51
The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. 49
Presence of cortistatin in the human pancreas. 48
Medroxyprogesterone acetate (MPA) stimulates adenylate cyclase activity in rat mammary tumours. 48
Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. 48
Natural and synthetic growth hormone secretagogues: do they have therapeutic potential? 47
Farmacologia degli ormoni ipotalamici 47
Targeting the ghrelin receptor: orally active GHS and cortistatin analogs. 46
Prolactin and interrenal hormone balance in Xenopus laevis adult specimens adapted to brackish water. 46
Prolactin receptors in human pituitary adenomas. 45
Farmacologia degli ormoni ipotalamici 45
Ghrelin: a metabolic signal affecting the reproductive system 45
GENERAL ANESTHESIA ABOLISHES THE ENDOCRINE BUT NOT THE CARDIOVASCULAR ACTIVITIES OF HEXARELIN, A GHRP, IN HUMANS 45
Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours 45
Ghrelin: endocrine and non-endocrine actions. 45
Natural and synthetic growth hormone-releasing peptides. 44
Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue. 42
Cortistatin: not simply a natural somatostatin analogue. 42
Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans 42
Ghrelin: from somatotrope to new perspectives in the regulation of peripheral metabolic function 42
Preliminary results on prolactin binding sites in Xenopus laevis brain and choroid plexus studied by radioautographic analysis. Difficulties and limits of the research. 42
Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor 42
Totale 8.240
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.886
article - articoli 0
book - libri 0
conference - conferenze 2.845
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.731
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019234 0 0 0 0 0 0 0 0 0 29 159 46
2019/20201.292 20 28 100 107 77 311 173 61 144 106 102 63
2020/20211.060 99 59 107 35 136 40 128 44 167 97 44 104
2021/20221.125 29 39 55 40 42 39 64 69 53 72 288 335
2022/20232.291 206 146 61 234 243 521 185 171 264 73 117 70
2023/2024948 137 146 93 156 71 132 71 80 22 40 0 0
Totale 9.612